Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.
Essand
Magnus
M
Clinical Immunology Division, Rudbeck Laboratory, Uppsala University, Sweden. magnus.essand@klinimm.uu.se
D000256:Adenoviridae / Q000235:genetics*; D000951:Antigens, Neoplasm / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use*; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000008:administration & dosage*; D006801:Humans; D007167:Immunotherapy; D008213:Lymphocyte Activation; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines